A Open-label Extension Study to Evaluate Long-term Safety and Efficacy With VX 509 in Subjects With Rheumatoid Arthritis on Disease-Modifying Antirheumatic Drugs

To evaluate the long-term safety and tolerability of VX-509 treatment in subjects with RA on DMARD therapy